EP1799240A4 - Treatment of bone disorders with skeletal anabolic drugs - Google Patents

Treatment of bone disorders with skeletal anabolic drugs

Info

Publication number
EP1799240A4
EP1799240A4 EP05797693A EP05797693A EP1799240A4 EP 1799240 A4 EP1799240 A4 EP 1799240A4 EP 05797693 A EP05797693 A EP 05797693A EP 05797693 A EP05797693 A EP 05797693A EP 1799240 A4 EP1799240 A4 EP 1799240A4
Authority
EP
European Patent Office
Prior art keywords
treatment
bone disorders
anabolic drugs
skeletal anabolic
skeletal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05797693A
Other languages
German (de)
French (fr)
Other versions
EP1799240A2 (en
Inventor
Andrew F Stewart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Osteotrophin LLC
Original Assignee
Osteotrophin LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Osteotrophin LLC filed Critical Osteotrophin LLC
Publication of EP1799240A2 publication Critical patent/EP1799240A2/en
Publication of EP1799240A4 publication Critical patent/EP1799240A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone (parathormone); Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EP05797693A 2004-09-16 2005-09-14 Treatment of bone disorders with skeletal anabolic drugs Withdrawn EP1799240A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US61028304P 2004-09-16 2004-09-16
PCT/US2005/032706 WO2006033912A2 (en) 2004-09-16 2005-09-14 Treatment of bone disorders with skeletal anabolic drugs

Publications (2)

Publication Number Publication Date
EP1799240A2 EP1799240A2 (en) 2007-06-27
EP1799240A4 true EP1799240A4 (en) 2009-07-22

Family

ID=36090476

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05797693A Withdrawn EP1799240A4 (en) 2004-09-16 2005-09-14 Treatment of bone disorders with skeletal anabolic drugs

Country Status (6)

Country Link
EP (1) EP1799240A4 (en)
JP (1) JP2008513459A (en)
AU (1) AU2005287139A1 (en)
CA (1) CA2580281A1 (en)
MX (1) MX2007003185A (en)
WO (1) WO2006033912A2 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3017668C (en) 2007-08-01 2021-11-09 The General Hospital Corporation Screening methods using g-protein coupled receptors and related compositions
AU2009356227A1 (en) 2009-12-07 2012-06-21 Michigan Technological University Black bear parathyroid hormone and methods of using black bear parathyroid hormone
US9492508B2 (en) 2010-05-13 2016-11-15 The General Hospital Corporation Parathyroid hormone analogs and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7015195B2 (en) * 2002-01-10 2006-03-21 Osteotrophin, Llc Treatment of bone disorders with skeletal anabolic drugs
US7906480B2 (en) * 2002-05-23 2011-03-15 Michael Holick Use of a parathyroid hormone peptide analogs for the treatment of vaginal atrophy

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
HORWITZ MARA J ET AL: "Short-term, high-dose parathyroid hormone-related protein as a skeletal anabolic agent for the treatment of postmenopausal osteoporosis.", THE JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM FEB 2003, vol. 88, no. 2, February 2003 (2003-02-01), pages 569 - 575, XP002530462, ISSN: 0021-972X *

Also Published As

Publication number Publication date
WO2006033912A3 (en) 2006-06-29
MX2007003185A (en) 2007-10-16
EP1799240A2 (en) 2007-06-27
AU2005287139A1 (en) 2006-03-30
JP2008513459A (en) 2008-05-01
WO2006033912B1 (en) 2006-09-08
WO2006033912A2 (en) 2006-03-30
CA2580281A1 (en) 2006-03-30

Similar Documents

Publication Publication Date Title
IL185052A0 (en) Treatment of bone disorders
HK1207821A1 (en) Improved modalities for the treatment of degenerative diseases of the retina
IL178815A0 (en) The treatment of respiratory disease
TWI372056B (en) Novel medicament combinations for the treatment of respiratory diseases
EP2166837A4 (en) Drug combination for the treatment of skin disorders
IL184425A0 (en) Cxcr4 antagonists for the treatment of medical disorders
IL188204A0 (en) Combination therapy for the treatment of immunoinflammatory disorders
EP1926521A4 (en) Devices and methods for delivering therapeutic substances for the treatment of sinusitis and other disorders
HK1171736A1 (en) Substituted acids for the treatment of respiratory diseases
IL178730A0 (en) New pharmaceutical compositions for the treatment of sexual disorders ii
GB0522311D0 (en) Pharmaceutical compositions for the treatment of pain
ZA200701584B (en) Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
ZA200801667B (en) Novel pharmaceutical combinations for the treatment of respiratory disorders
EP1962869A4 (en) Treatment of respiratory diseases
GB0404656D0 (en) Treatment of spinal conditions
GB0410399D0 (en) The treatment of respiratory disease
HK1111599A1 (en) Pharmaceutical compositions for the treatment of cellulite
EP1799240A4 (en) Treatment of bone disorders with skeletal anabolic drugs
GB0400802D0 (en) Compounds for the treatment of disease
EP1846013A4 (en) Treatment of skin diseases
ZA200607463B (en) New pharmaceutical compositions for the treatment of sexual disorders II
GB0419828D0 (en) The treatment of inflammatroy disorders and pain
GB0417474D0 (en) Treatment of respiratory disorders
GB0423245D0 (en) Treatment of breathing disorders
GB0520152D0 (en) Treatment of respiratory disease

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20070412

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20090618

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20090918